TSLP and hepatocellular carcinoma: We found MVD in the tumor tissues treated with the anti-TSLP antibody was significantly decreased compared with the vehicle group; however, MVD in the HCC tissues treated with the anti-TSLP antibody and YPFS did not cause further significant inhibition compared with the group treated with YPFS only (P < 0.01; Figure 4(a)), and the expression changed VEGF in accordance with the MVD (P < 0.01; Figure 4(b)).